DANBURY, CT, April 29, 2026 – Canopy Life Sciences, a global leader in Medical, Legal, and Regulatory (MLR) services, launches Scout by Canopy (“Scout”), an AI-powered platform designed to modernize MLR content review. The Scout platform combines structured AI with purpose-built technology to support MLR content review across the entire lifecycle, from early creative development through final approval. Scout gives brands, agencies, medical writers, and reviewers a single platform to evaluate content.
Susanne Clark, CEO of Canopy, said, “Canopy is the industry leader in MLR Solutions. Meaningful innovation in MLR must drive clarity and trust, integrate with existing processes organically, and, above all, support human accountability and excellence for this critically important process. Scout is a truly transformative platform for content integrity, and we’re thrilled to bring it to market.”
What sets Scout apart is its foundation, how it presents findings, and how it incorporates into the MLR workflow. Scout evaluates content across medical, regulatory, and legal disciplines, validating each claim against approved evidence, prescribing information, and regulatory precedent. Every finding is fully traceable and auditable, supported by clear, source-based rationale that reviewers can assess and defend. Scout is designed to augment the expertise already in place, streamlining analysis and surfacing high-value insights to enable more efficient, confident decision-making.
Joanna Bova, SVP Client Strategy & Enablement and Head of MLR, said, “Canopy is built on authentic collaboration, a commitment to best practices, technology that works for people, and a spirit of continuous improvement and progress. For decades, MLR teams have struggled, through no fault of their own, with systems that weren’t designed for their needs and with rework driven by the complexities of the content lifecycle. Scout is the first platform to truly prioritize their time by supporting high-quality content across the entire lifecycle.”
Scout is built on enterprise-grade infrastructure designed to meet the demands of life sciences organizations. This architecture provides robust security, strict data isolation, and high-performing models, while enabling Canopy to seamlessly integrate emerging AI capabilities as the landscape evolves.
For more information about Scout and pilot program partnerships, please visit our site.
About Canopy Life Sciences:
Canopy Life Sciences supports over 300 biotechnology, pharmaceutical, and medical device companies with a full suite of MLR services, including Operations Support, Advisory, Medical Review, Regulatory Ad Promo, Agency Submission Services, and Veeva Support. Learn more at www.hellocanopy.com.
Media Contact
Annie Downing
Vice President, Commercial
P: 330-730-3136
annie.downing@hellocanopy.com
